To compare the lipoprotein phenotype between FDB and heterozygous familial hypercholesterolemia (FH); to study the prevalence and possible founder effect of familial ligand-defective apo B100 (FDB) ...in a Mediterranean population, and to analyze the clinical and biochemical characteristics of FDB patients.
We studied 19 heterozygous FDB subjects (8 males) from 12 related families, carriers of the R3500Q mutation on the apo B gene, and 57 heterozygous FH (24 males) genetically characterized, randomly selected from a total of 213 FH. The genetic diagnosis was established with Southern blot analysis, PCR-SSCP analysis and automatic sequencing. In all subjects, plasma lipids and apolipoprotein levels were determined with standard procedures.
We demonstrated a founder effect for the R3500Q mutation in a geographically isolated rural area from our community. The prevalence of FDB in this area is high: 4/350. Heterozygous FDB subjects showed a statistical significantly lower prevalence of xanthomas and coronary heart disease, plasma concentrations of total and LDL cholesterol, HDL cholesterol, apo B and apo A-I values than heterozygous FH subjects.
A founder effect for the R3500Q mutation was found in a rural population with a high prevalence of FDB. In our population, FDB patients showed a mild clinical expression and lipoprotein phenotype compared with FH patients.
Waist-to-height ratio, inflammation and CVD risk in obese children Olza, Josune; Concepcion M AguileraauthorDepartment of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology, Centre for Biomedical Research (CIB), Lab 123, University of Granada, Avda. del Conocimiento s/n, 18016 Armilla, Granada, Spain; Mercedes Gil-CamposauthorPaediatric Research and Metabolism Unit, Reina Sofa University Hospital, Maimonides Institute for Biomedical Research (IMIBIC) and Unit of Paediatric Endocrinology, Cordoba, Spain ...
2015
Journal Article
PDF
